RA Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,535
Closed -$3.65M 27
2018
Q3
$3.65M Hold
2,535
0.2% 25
2018
Q2
$4.09M Hold
2,535
0.27% 25
2018
Q1
$4.12M Buy
+2,535
New +$4.12M 0.32% 27